Bibliography
- RUSSEL MGVM: Changes in the incidence of inflammatory bowel diseases: what does it mean? Eur: J. Int. Med. (2000) 11:191–196.
- LOFTUS EV, SANDBORN WJ: Epidemiology of inflammatory bowel disease. Castronterol. Cl/n. North Am. (2002) 31:1–20.
- •Extensive review of reported studies on incidence and prevalence of IBD worldwide.
- PUNCHARD NA: Inflammatory bowel disease: something old, something new? Curt: Opin. Investig. Drugs (2000) 2:272–274.
- CHUTKAN RK: Inflammatory bowel disease. Prim. Care (2001) 28:539–56.
- OGURA Y, INOHARA N, BENETO A, CHEN FC, YAMAOKA S, NONUEZ G: Nod2, a Nodl/Apaf-1 family member that is restricted to monocytes and activates NHcB. Biol. Chem. (2001) 276: 4812–4818.
- HUGOTJ-P, CHAMAILLARD M, ZOUALI H et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 411:599–603.
- HAMPE J, CUTHBERT A, CROUCHER PJP et al.: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 357: 1925-1928.
- OGURA Y, BONEN DK, INOHARA N et al: A frame-shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 411:603–606.
- INOHARA N, KOSEKI T, DEL PESO L et al: NOD-1, an Apaf-1-like activator of caspase 9 and nuclear factor-KB. Biol. Chem. (1999) 274:14560–14567.
- INOHARA N, KOSEKI T, LIN J et al: An induced proximity model for NFicB activation in the Nodl/RICK and RIP signalling pathways. Biol. Chem. (2000) 275:27823–27831.
- INOHARA N, GUNEZ G: The NOD: a signalling module that regulates apoptosis and host defense against pathogens. Oncogene (2001) 20:6473–6481.
- KOBASHI K, INOHARA N, HERNANDEZ LD et al.: RICK/Rip2/ CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature (2002) 416:194–199.
- INOHARA N, OGURA Y, CHEN FC, MUTO A, NOICTUEZ G: Human Nodl confers responsiveness to bacterial lipopolysaccharides..I. Biol. Chem. (2001) 276:2551–2554.
- GIRADIN SE, SANSONETTI, PJ, PHILPOTT DJ: Intracellular versus extracellular recognition of pathogens - common concepts in mammals and flies. Trends Microbiol (2002) 10:193–199.
- BERTIN J, NIRS W-J, FISCHER CM etal.: Human CARD4 protein is a novel CED-4/ Apaf-1 cell death family member that activates NFicB. Biol Chem. (1999) 274:12955–12958.
- GIRARDIN SE, TOURNEBIZE R, MAVRIS M et at CARD4/Nod1 mediates NF-icB and JNK activation by invasive Shigella flexneri EMBO Rep. (2001) 2:736–742.
- HAMPE J, GREBE J, NIKOLAUS S et al: Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet (2002) 359: 1661-1665.
- CUTHBERT AP, FISHER SA, MIRZZA MM et al.: The contribution of NOD2 gene mutations to the risk and site of diseases in inflammatory bowel disease. Gastroenetrology (2002) 122:867–874.
- LESAGE S, ZOUALI H, CEZARD J-P et al.: CARD15/NOD2 mutational analysis and the genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am Hum Genet (2002) 70:845–857.
- AHMAD T, ARMUZZI A, BUNCE M et al.: The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology (2002) 122:1161–1162.
- RADLMAYR M, TOROK HP, MARTIN K, FOLWACZNY C: The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 122:2091–20952.
- CRANE AM, BRADBURY, L, VAN HEEL DA et al.: Role of Nod2 variant in spondylarthritis. Arthritic Rheum. (2002) 46:1629–1633.
- VAN HEEL DA, UDALOVA IA, DE SILVA AP et al.: Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between OCT1 and NF-icB transcription factors. Hum. Mol Genet. (2002) 11:1281–1289.
- MICELLI-RICHARD C, LESAGE S, RYBOJAD M et al.: CARD15 mutations in blau syndrome. Nat. Genet. (2001) 29:19–20.
- NAIR RP, STUART P, OGURA Yet al.: Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. Invest. Berm. (2001) 117:1671–1672.
- BEUTLER B: Autoimmunity and Apoptosis: The Crohn's Connection. Immunity (2001) 15:5–14.
- ••A recent review critically evaluating theevidence put forward for the role of Nod proteins.